täiskirje prindi

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

autor
Elshorbagy, Amany
Lyons, Alexander R.M.
Vallejo-Vaz, Antonio J.
Stevens, Christophe A.T.
Dharmayat, Kanika Inamdar
Brandts, Julia
Catapano, Alberico L.
Freiberger, Tomas
Hovingh, Gerard Kees Kornelis
Viigimaa, Margus
vastutusandmed
Amany Elshorbagy, Alexander R.M. Lyons, Antonio J. Vallejo-Vaz, Christophe A.T. Stevens, Kanika I. Dharmayat, Julia Brandts, Alberico L. Catapano, Tomas Freiberger, G. Kees Hovingh, M. Viigimaa et al.
allikas
The Lancet Diabetes and Endocrinology
kirjastus/väljaandja
ajakirja aastakäik number kuu
vol. 12, 11
ilmumisaasta
leheküljed
p. 811-823
leitav
ISSN
2213-8587
märkused
Bibliogr.: 28 ref
Open Access
Open Access
teaduspublikatsioon
teaduspublikatsioon
keel
inglise
Elshorbagy, A., Lyons, A.R.M., Vallejo-Vaz, A.J., Stevens, C.A.T., Dharmayat, K.I., Brandts, J., Catapano, A.L., Freiberger, T., Hovingh, G. K., Viigimaa, M. et al. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study // The Lancet Diabetes and Endocrinology (2024) vol. 12, 11, p. 811-823. https://doi.org/10.1016/S2213-8587(24)00221-3